According to a law firm press release, plaintiffs filed a class action lawsuit on behalf of all purchasers of China Shenghuo Pharmaceutical Holdings, Inc. allegiving violations of the Securities Exchange Act of 1934.
The complaint charges that CSP and certain of its officers and directors violated Sections 10(b) and 20(a) of the 1934 Act by issuing materially false and misleading statements pertaining to CSP's business prospects and condition, and filing materially false financial statements with the SEC. On August 20, 2008, the Company announced that its previously issued financial statements for the fiscal periods ended June 30, September 30, and December 30, 2007 and fiscal quarter ended March 31, 2008, should no longer be relied upon and would be restated due to certain accounting errors, internal control issues and related matters. News that the Company's financial statements must be restated caused the Company's stock price to fall dramatically damaging investors.
If you bought China Shenghuo Pharmaceutical Holdings, Inc. securities and would like to obtain information about the China Shenghuo Pharmaceutical Holdings, Inc. lawsuit, then you are invited to call Kahn Gauthier Swick, LLC toll free at (866) 467-1400 to speak with an attorney or visit www.kgscounsel.com.